Liebman J, Neale R, Moen N J
Eur J Pharmacol. 1978 Aug 15;50(4):377-83. doi: 10.1016/0014-2999(78)90143-7.
Despite its clinical efficacy as an antipsychotic agent, sulpiride differs from other neuroleptics in that it has been reported to exert erratic effects in several animal models. The effects of sulpiride were investigated on Sidman avoidance responding by the rat and squirrel monkey. At 100 mg/kg i. p. or orally, sulpiride failed to impair rat Sidman avoidance responding appreciably while exerting marginally toxic effects, but at 30 mg/kg orally, this drug strongly impaired Sidman avoidance responding by the squirrel monkey. This effect, which manifested delayed onset, was reversed by benztropine, indicating that dopamine receptor blockade was most likely responsible for the impairment of responding. The gross behavioral effects of sulpiride in the squirrel monkey resembled those of haloperidol, and dyskinetic postures induced by haloperidol could be mimicked by sulpiride in some instances. It is concluded that the behavioral effects of sulpiride in the rat may not be representative of its action in primates or in the clinic.
尽管舒必利作为一种抗精神病药物具有临床疗效,但它与其他神经阻滞剂不同,据报道它在几种动物模型中会产生不稳定的效果。研究了舒必利对大鼠和松鼠猴的西德曼回避反应的影响。腹腔注射或口服100mg/kg舒必利时,虽然会产生轻微毒性作用,但并未明显损害大鼠的西德曼回避反应;但口服30mg/kg时,该药物会强烈损害松鼠猴的西德曼回避反应。这种作用表现为起效延迟,可被苯海索逆转,表明多巴胺受体阻断很可能是反应受损的原因。舒必利对松鼠猴的总体行为影响与氟哌啶醇相似,在某些情况下,舒必利可以模拟氟哌啶醇诱导的运动障碍姿势。得出的结论是,舒必利对大鼠的行为影响可能无法代表其在灵长类动物或临床上的作用。